R. Aymon Et Al. , "Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with JAK-inhibitors compared to bDMARDs: data from an international collaboration of registries (the "JAK-pot" study)," SWISS MEDICAL WEEKLY , 2023
Aymon, R. Et Al. 2023. Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with JAK-inhibitors compared to bDMARDs: data from an international collaboration of registries (the "JAK-pot" study). SWISS MEDICAL WEEKLY .
Aymon, R., Mongin, D., Bergstra, S. A., Choquette, D., Codreanu, C., Cordtz, R. L., ... De Cock, D.(2023). Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with JAK-inhibitors compared to bDMARDs: data from an international collaboration of registries (the "JAK-pot" study). SWISS MEDICAL WEEKLY .
Aymon, R. Et Al. "Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with JAK-inhibitors compared to bDMARDs: data from an international collaboration of registries (the "JAK-pot" study)," SWISS MEDICAL WEEKLY , 2023
Aymon, R. Et Al. "Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with JAK-inhibitors compared to bDMARDs: data from an international collaboration of registries (the "JAK-pot" study)." SWISS MEDICAL WEEKLY , 2023
Aymon, R. Et Al. (2023) . "Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with JAK-inhibitors compared to bDMARDs: data from an international collaboration of registries (the "JAK-pot" study)." SWISS MEDICAL WEEKLY .
@article{article, author={R. Aymon Et Al. }, title={Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with JAK-inhibitors compared to bDMARDs: data from an international collaboration of registries (the "JAK-pot" study)}, journal={SWISS MEDICAL WEEKLY}, year=2023}